Roland E Schmieder Selected Research

Ramipril (Altace)

1/2021	Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
1/2021	Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke.
10/2020	Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.
1/2020	Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
11/2017	Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients.
6/2017	Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
1/2017	Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
12/2015	The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
10/2010	Renal protection in diabetes: lessons from ONTARGET.
12/2009	Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland E Schmieder Research Topics

Disease

165	Hypertension (High Blood Pressure) 05/2022 - 01/2002
36	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2003
28	Essential Hypertension 01/2019 - 01/2002
26	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 04/2002
19	Stroke (Strokes) 01/2022 - 04/2007
17	Albuminuria 05/2021 - 04/2006
14	Heart Failure 01/2022 - 05/2005
14	Diabetic Nephropathies (Diabetic Nephropathy) 05/2021 - 04/2006
12	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 08/2004
11	Proteinuria 01/2018 - 05/2005
10	Chronic Renal Insufficiency 05/2022 - 03/2013
10	Inflammation (Inflammations) 02/2019 - 05/2005
9	Diabetes Mellitus 05/2021 - 07/2006
9	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2019 - 11/2002
8	Myocardial Infarction 01/2022 - 04/2009
8	Hypercholesterolemia 09/2011 - 02/2003
7	Vascular Remodeling 12/2021 - 10/2007
6	Fibrosis (Cirrhosis) 06/2022 - 01/2003
5	Microvascular Rarefaction 01/2018 - 01/2016
5	Coronary Artery Disease (Coronary Atherosclerosis) 11/2010 - 07/2003
4	Vascular Diseases (Vascular Disease) 01/2021 - 08/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2015 - 04/2009
3	Neoplasms (Cancer) 01/2022 - 01/2020
3	Isolated Systolic Hypertension 12/2016 - 11/2004
3	Hypertrophy 11/2014 - 02/2003
3	Cognitive Dysfunction 09/2014 - 07/2008
2	Coronary Disease (Coronary Heart Disease) 10/2021 - 01/2013
2	Peripheral Arterial Disease 10/2021 - 09/2017
2	Dyslipidemias (Dyslipidemia) 01/2021 - 08/2009
2	Body Weight (Weight, Body) 01/2021 - 01/2019
2	Ganglion Cysts (Ganglion) 01/2020 - 12/2019
2	Hyperaldosteronism (Conn Syndrome) 07/2017 - 01/2016
2	Insulin Resistance 01/2017 - 06/2014

Drug/Important Bio-Agent (IBA)

52	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 11/2002
28	Retinaldehyde (Retinal)IBA 12/2021 - 01/2006
20	Telmisartan (Micardis)FDA Link 01/2021 - 11/2004
19	Angiotensin Receptor AntagonistsIBA 11/2016 - 11/2002
18	Ramipril (Altace)FDA LinkGeneric 01/2021 - 04/2006
17	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2017
17	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2016 - 04/2002
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2015 - 07/2003
14	DiureticsIBA 01/2022 - 01/2003
13	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2015 - 12/2002
12	AlbuminsIBA 10/2021 - 10/2007
11	CreatinineIBA 01/2022 - 07/2009
11	Valsartan (Vals)FDA Link 11/2016 - 12/2002
11	Amlodipine (Norvasc)FDA LinkGeneric 02/2015 - 12/2003
10	SodiumIBA 12/2021 - 01/2003
10	Pharmaceutical PreparationsIBA 01/2021 - 12/2012
9	olmesartanIBA 11/2017 - 12/2010
9	Angiotensin IIIBA 09/2011 - 01/2002
8	AldosteroneIBA 05/2017 - 01/2002
8	Nitric Oxide Synthase (NO Synthase)IBA 12/2016 - 10/2004
8	SaltsIBA 02/2014 - 01/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2013 - 03/2005
7	LDL CholesterolIBA 01/2018 - 03/2008
7	aliskiren FDA Link 10/2016 - 03/2005
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 02/2008
6	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2012
6	C-Reactive ProteinIBA 02/2019 - 05/2005
6	ReninIBA 11/2016 - 06/2005
6	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 10/2014 - 10/2004
6	Losartan (Cozaar)FDA LinkGeneric 09/2011 - 11/2002
5	empagliflozinIBA 12/2021 - 01/2017
5	LipidsIBA 01/2019 - 06/2003
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2018 - 02/2008
4	Peptides (Polypeptides)IBA 06/2022 - 02/2008
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2017
4	finerenoneIBA 05/2021 - 01/2014
4	Mineralocorticoid Receptor AntagonistsIBA 05/2021 - 01/2014
4	candesartanIBA 01/2021 - 10/2005
4	CholesterolIBA 06/2020 - 06/2003
4	oxidized low density lipoproteinIBA 01/2018 - 07/2011
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2015 - 07/2002
4	Irbesartan FDA LinkGeneric 04/2014 - 07/2004
4	Arginine (L-Arginine)FDA Link 02/2011 - 06/2003
3	LinagliptinIBA 01/2021 - 12/2016
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 10/2007
3	CytokinesIBA 06/2016 - 05/2005
3	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2014 - 10/2004
3	PotassiumIBA 01/2014 - 11/2011
3	manidipineIBA 01/2013 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 05/2011 - 09/2004
3	CalciumIBA 09/2010 - 07/2003
3	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 04/2010 - 01/2002
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2009 - 07/2006
2	MineralsIBA 02/2019 - 12/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2019 - 05/2005
2	Vitamin D FDA LinkGeneric 02/2019 - 04/2013
2	Insulin (Novolin)FDA Link 09/2017 - 04/2008
2	Eplerenone (Inspra)FDA LinkGeneric 07/2017 - 01/2017
2	MineralocorticoidsIBA 07/2017 - 11/2008
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2016 - 01/2003

Therapy/Procedure

58	Denervation 05/2022 - 12/2010
49	Therapeutics 01/2022 - 12/2002
20	Catheters 05/2022 - 12/2010
8	Lasers (Laser) 01/2021 - 05/2012
7	Renal Dialysis (Hemodialysis) 06/2022 - 08/2004
6	Sympathectomy (Sympathectomies) 08/2015 - 12/2010
3	Drug Therapy (Chemotherapy) 08/2017 - 12/2012